HPV, the Vaccine, and Cancer

Nearly 80% of sexually active people in the United States will have a genital HPV infection at some point in their lives. Over 30,000 people will be diagnosed with an HPV-related cancer in the next year in the United States. It is the agent responsible for venereal warts and is the most important factor in the development of cervical cancer in women, and the increasing head and neck cancers in men.

With more than half of a million new cases diagnosed each year, cervical cancer is the most common gynecological cancer worldwide, and it’s preventable. In this episode, Dr. Mendivil discusses the vaccine for HPV and what people can do to protect themselves.

About Our Guest

Dr. Alberto Mendivil is certified by both The America Board of Obstetrics and Gynecology, and The American Board of Obstetrics and Gynecology, Gynecologic Oncology. He received his medical degree at the University of Utah School of Medicine and completed his internship and residency in Obstetrics and Gynecology at the University of California, Irvine. His Fellowship training in Gynecologic Oncology was completed at the University of North Carolina, Chapel Hill. Dr. Mendivil is also the author of numerous scholarly publications related to gynecological oncology.